Intracellular macrophage growth rates and cytokine profiles of Mycobacterium tuberculosis strains with different transmission dynamics

Journal of Infectious Diseases

Volumn 191, Issue 3, 2005, Pages 453-460

  Theus, Sue A ^a   Cave, M Donald ^a   Eisenach, Kathleen D ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR;

ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GROWTH RATE; HUMAN; HUMAN CELL; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

CELL LINE; CYTOKINES; DNA TRANSPOSABLE ELEMENTS; HUMANS; INTERLEUKIN-10; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDES; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 12344274326     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/425936     Document Type: Article

References (14)

1. Manca C, Tsenova L, Barry CE 3rd, et al. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol 1999; 162:6740-6.
2. Manca C, Tsenova L, Bergtold A, et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β. Proc Natl Acad Sci USA 2001; 98:5752-7.
3. Li Q, Whalen CC, Albert JM, et al. Differences in rate and variability of intracellular growth of a panel of Mycobacterium tuberculosis clinical isolates within a human monocyte model. Infect Immun 2002; 70: 6489-93.
4. Theus SA, Cave MD, Eisenach KD. Activated THP-1 cells: an attractive model for the assessment of intracellular growth rates of Mycobacterium tuberculosis isolates. Infect Immun 2004; 72:1169-73.
5. Zhang M, Gong J, Yang Z, Samten B, Cave MD, Barnes PF. Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. J Infect Dis 1999; 179:1213-7.
6. Stokes RW, Doxsee D. The receptor-me dialed uptake, survival, replication, and drug sensitivity of Mycobacterium tuberculosis within the macrophage-like cell line THP-1: a comparison with human monocyte-derived macrophages. Cell Immunol 1999; 197:1-9.
7. Crawford JT, Braden CR, Schable BA, Onorato IM. National tuberculosis genotyping and surveillance network: design and methods. Emerg Infect Dis 2002; 8:1192-6.
8. Yang Z, Barnes PF, Chaves F, Eisenach KD, et al. Diversity of DNA fingerprints of Mycobacterium tuberculosis in the United States. J Clin Microbiol 1998; 36:1003-7.
9. Wu S, Howard ST, Lakey DL, Kipnis A, et al. The principal sigma factor sigA mediates enhanced growth of Mycobacterium tuberculosis in vivo. Mol Microbiol 2004; 51:1551-62.
10. Giacomini E, Iona E, Ferroni L, et al. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol 2001; 166:7033-41.
11. Bogdan C, Moll H, Solbach W, Rollinghoff M. Tumor necrosis factor-α in combination with interferon-γ, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes. Eur J Immunol 1990; 20:1131-5.
12. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991; 174:1549-55.
13. Boussiotis VA, Tsai EY, Yunis EJ, et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000; 105:1317-25.
14. Vankayalapati R, Wizel B, Weis SE, et al. Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis. Clin Infect Dis 2003; 36:24-8.